Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action.

BACKGROUND:Despite an overall decrease in incidence of and mortality from cancer, about 40% of Americans will be diagnosed with the disease in their lifetime, and around 20% will die of it. Current approaches to test carcinogenic chemicals adopt the 2-year rodent bioassay, which is costly and time-c...

Full description

Bibliographic Details
Main Authors: Daniel Gusenleitner, Scott S Auerbach, Tisha Melia, Harold F Gómez, David H Sherr, Stefano Monti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4109923?pdf=render